ORPHAZYME A/S - ADR (ORPH) Stock Cash Flow
NASDAQ:ORPH - Nasdaq - ADR
| TTM (2021-6-30) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -853.39M | -633.25M | -335.95M | -231.65M | -131.04M | |||
| Depreciation Amortization | 19.76M | 5.20M | 3.80M | 1.37M | 627.00K | |||
| Change In Working Capital | 64.51M | 36.15M | 2.78M | -6.09M | 34.75M | |||
| Interest Paid | 9.82M | 10.72M | 4.79M | 2.96M | 662.00K | |||
| Taxes Paid | N/A | 1.43M | N/A | N/A | N/A | |||
| Other non cash items | 52.49M | 52.82M | 2.55M | 1.61M | 241.00K | |||
| OPERATING CASH FLOW | -716.63M | -539.08M | -326.82M | -234.76M | -95.43M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -4.15M | -5.10M | -3.29M | -2.35M | -1.49M | |||
| INVESTING CASH FLOW | -4.15M | -5.10M | -3.29M | -2.35M | -1.49M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -26.14M | -13.51M | 58.92M | N/A | N/A | |||
| Stock Issued/Repurchased | 533.71M | 1.28B | 19.00K | 0.00 | 600.00M | |||
| Other Financing Activity | -56.62M | -107.86M | N/A | 0.00 | 114.30M | |||
| FINANCING CASH FLOW | 450.95M | 1.16B | 58.94M | 0.00 | 714.30M | |||
| Exchange Rate Effect | -6.44M | -11.90M | 46.00K | 81.00K | N/A | |||
| CHANGE IN CASH | -276.26M | 603.34M | -271.12M | -237.03M | 617.39M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -716.63M | -539.08M | -326.82M | -234.76M | -95.43M | |||
| Capital Expenditure | -4.15M | -5.10M | -3.29M | -2.35M | -1.49M | |||
| FREE CASH FLOW | -720.78M | -544.18M | -330.10M | -237.11M | -96.92M | |||
All data in DKK